Gilead Sciences, Inc.
GILD
Below: live stock price for Gilead Sciences, Inc. (GILD), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
Gilead Sciences, Inc. (GILD) trades at 149.74 USD on investpig.
- Prev close
- $149.61
- Volume (24h)
- $110.62M
- Market cap
- $185.67B
- Currency
- USD
Score
Insufficient data
- Value—
- Quality—
- Momentum—
- Growth—
- Risk—
- Dividend—
- Liquidity—
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 151.5285 +1.19%
- +20 bars
- 154.0314 +2.87%
- +60 bars
- 155.0107 +3.52%
- +120 bars
- 155.0468 +3.54%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0259 USD.
Interpretation
Price sits near the upper third of the recent range, trend is sloping upward.
Descriptive observation — not investment advice.
Price report
How this asset has actually moved over the last 253 days.
Where the price sits between the window low and high.
- Volatility (annualised)
- 26.5%
- Max drawdown
- -22.0%
- Below period high
- -4.8%
- Best day
- +5.82%
- Worst day
- -3.72%
- Up days
- 52%
- Current streak
- 1 up
- Typical day swing
- 2.5%
- Volume vs average
- -23%
Spread of returns. Higher means larger swings in both directions.
Worst peak-to-trough fall inside the window.
Current price against the highest point in the window.
Share of days that closed above the one before.
Average high-to-low spread within a single day.
Last 10 days against the whole window.
Descriptive statistics over past prices — not a forecast and not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
Levels derived from: 152.55 high → 121.39 low · 60 bars
- ResistanceFib +161.8% extensionnot reached202.9669 USD+35.55% from current
- ResistanceFib +100% extensionnot reached183.71 USD+22.69% from current
- ResistanceFib +61.8% extensionnot reached171.8069 USD+14.74% from current
- ResistanceFib +27.2% extensionnot reached161.0255 USD+7.54% from current
- Current149.74 USD
- SupportFib 23.6% retracementNearesttested 6×145.1962 USD-3.03% from current
- SupportFib 38.2% retracementtested 1×140.6469 USD-6.07% from current
- SupportFib 50% midpointtested 7×136.97 USD-8.53% from current
- SupportFib 61.8% retracementtested 13×133.2931 USD-10.98% from current
- SupportFib 78.6% retracementtested 8×128.0582 USD-14.48% from current
- SupportFib −27.2% extensionnot reached112.9145 USD-24.59% from current
- SupportFib −61.8% extensionnot reached102.1331 USD-31.79% from current
- SupportFib −100% extensionnot reached90.23 USD-39.74% from current
How to read this
We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.
“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.
This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.
Recent news
- The Quiet Ohio Enclave Known for Prestige, Privacy and Now Travis KelceThe Wall Street Journal16h ago
- Gilead (GILD) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks1d ago
- Can Bixlenvo Unlock New Growth for Gilead's HIV Business?Zacks1d ago
- Healthcare ETF Comparison: Fidelity's FHLC vs. Invesco's Biotech-Focused IBBQMotley Fool22h ago
- Can LLY's Merida Deal Boost Its M&A Push to Diversify Beyond GLP-1s?Zacks1d ago
- Bernie Sanders Sounds Alarm on ‘Rigged’ US Economy Amid Growing Wealth Inequality, Says Elon Musk Is Richer Than Half of American HouseholdsBenzinga1d ago
- Gilead takes a ‘different’ approach to reaching the Black community with new HIV campaignPharma Voice1d ago
- Wall Street Analysts See Gilead (GILD) as a Buy: Should You Invest?Zacks2d ago
Related
Other assets in this category.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,754 USD+1.90%
- 7203.TToyota Motor Corporation3,117 USD-0.51%
- 9984.TSoftBank Group Corp.5,001 USD+1.56%
- 6758.TSony Group Corporation3,895 USD-0.64%
- 6861.TKeyence Corporation77,980 USD-0.05%
- NVDANVIDIA Corporation226.145 USD+0.77%
- AAPLApple Inc.329.42 USD+1.37%
- GOOGLAlphabet Inc.341.435 USD+1.28%
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.